-
1
-
-
85003443860
-
Deep vein thrombosis and pulmonary embolism
-
Di Nisio M, van Es N, Büller HR. Deep vein thrombosis and pulmonary embolism. Lancet 2016;388:3060-73.
-
(2016)
Lancet
, vol.388
, pp. 3060-3073
-
-
Di Nisio, M.1
Van Es, N.2
Büller, H.R.3
-
2
-
-
84938198885
-
Epidemiology of venous thromboembolism
-
Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol 2015;12:464-74.
-
(2015)
Nat Rev Cardiol
, vol.12
, pp. 464-474
-
-
Heit, J.A.1
-
3
-
-
84958038787
-
Antithrombotic therapy for vte disease: Chest guideline and expert panel report
-
Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016;149:315-52.
-
(2016)
Chest
, vol.149
, pp. 315-352
-
-
Kearon, C.1
Akl, E.A.2
Ornelas, J.3
-
4
-
-
84897509629
-
Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism
-
Kearon C, Akl EA. Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood 2014;123:1794-801.
-
(2014)
Blood
, vol.123
, pp. 1794-1801
-
-
Kearon, C.1
Akl, E.A.2
-
5
-
-
77952524191
-
Systematic review: Case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism
-
Carrier M, Le Gal G, Wells PS, et al. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann intern med 2010;152:578-89.
-
(2010)
Ann Intern Med
, vol.152
, pp. 578-589
-
-
Carrier, M.1
Le Gal, G.2
Wells, P.S.3
-
6
-
-
84884548759
-
Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: Systematic review and network meta-Analysis
-
Castellucci LA, Cameron C, Le Gal G, et al. Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-Analysis. BMJ 2013;347:f5133.
-
(2013)
BMJ
, vol.347
, pp. f5133
-
-
Castellucci, L.A.1
Cameron, C.2
Le Gal, G.3
-
7
-
-
84859000239
-
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: Analysis of individual participants' data from seven trials
-
Boutitie F, Pinede L, Schulman S, et al. Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials. BMJ 2011;342:d3036.
-
(2011)
BMJ
, vol.342
, pp. d3036
-
-
Boutitie, F.1
Pinede, L.2
Schulman, S.3
-
8
-
-
77955427593
-
Unprovoked venous thromboembolism: Short term or indefinite anticoagulation? Balancing long-term risk and benefit
-
Rodger M, Carrier M, Gandara E, et al. Unprovoked venous thromboembolism: short term or indefinite anticoagulation? balancing long-term risk and benefit. Blood rev 2010;24:171-8.
-
(2010)
Blood Rev
, vol.24
, pp. 171-178
-
-
Rodger, M.1
Carrier, M.2
Gandara, E.3
-
9
-
-
84937207208
-
Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: The padis-pe randomized clinical trial
-
Couturaud F, Sanchez O, Pernod G, et al. Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: The PADIS-PE randomized clinical trial. JAMA 2015;314:31-40.
-
(2015)
JAMA
, vol.314
, pp. 31-40
-
-
Couturaud, F.1
Sanchez, O.2
Pernod, G.3
-
10
-
-
84911864852
-
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism
-
Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014;35:3033-69.
-
(2014)
Eur Heart J
, vol.35
, pp. 3033-3069
-
-
Konstantinides, S.V.1
Torbicki, A.2
Agnelli, G.3
-
11
-
-
84964318237
-
Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort
-
Rodger MA, Scarvelis D, Kahn SR, et al. Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: a multi-national cohort. Thromb res 2016;143:152-8.
-
(2016)
Thromb Res
, vol.143
, pp. 152-158
-
-
Rodger, M.A.1
Scarvelis, D.2
Kahn, S.R.3
-
12
-
-
85003888960
-
The long-term recurrence risk of patients with unprovoked venous thromboembolism: An observational cohort study
-
Kyrle PA, Kammer M, Eischer L, et al. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study. J thromb haemost 2016;14:2402-9.
-
(2016)
J Thromb Haemost
, vol.14
, pp. 2402-2409
-
-
Kyrle, P.A.1
Kammer, M.2
Eischer, L.3
-
13
-
-
78649359714
-
Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: Recommendation for acceptable rates and standardized reporting
-
Kearon C, Iorio A, Palareti G. Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting. J Thromb Haemost 2010;8:2313-5.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 2313-2315
-
-
Kearon, C.1
Iorio, A.2
Palareti, G.3
-
14
-
-
79952255467
-
Risk of recurrence after venous thromboembolism in men and women: Patient level metaanalysis
-
Douketis J, Tosetto A, Marcucci M, et al. Risk of recurrence after venous thromboembolism in men and women: patient level metaanalysis. BMJ 2011;342:d813.
-
(2011)
BMJ
, vol.342
, pp. d813
-
-
Douketis, J.1
Tosetto, A.2
Marcucci, M.3
-
15
-
-
53749084691
-
Systematic review: D-dimer to predict re-current disease after stopping anticoagulant therapy for unprovoked venous thromboembolism
-
Verhovsek M, Douketis JD, Yi Q, et al. Systematic review: D-dimer to predict re-current disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann intern med 2008;149:481-90.
-
(2008)
Ann Intern Med
, vol.149
, pp. 481-490
-
-
Verhovsek, M.1
Douketis, J.D.2
Yi, Q.3
-
16
-
-
77950920123
-
Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: The vienna prediction model
-
Eichinger S, Heinze G, Jandeck LM, et al. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation 2010;121:1630-6.
-
(2010)
Circulation
, vol.121
, pp. 1630-1636
-
-
Eichinger, S.1
Heinze, G.2
Jandeck, L.M.3
-
17
-
-
84861684787
-
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: A proposed prediction score (dash
-
Tosetto A, Iorio A, Marcucci M, et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J thromb haemost 2012;10:1019-25.
-
(2012)
J Thromb Haemost
, vol.10
, pp. 1019-1025
-
-
Tosetto, A.1
Iorio, A.2
Marcucci, M.3
-
18
-
-
50649107286
-
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
-
Rodger MA, Kahn SR, Wells PS, et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 2008;179:417-26.
-
(2008)
CMAJ
, vol.179
, pp. 417-426
-
-
Rodger, M.A.1
Kahn, S.R.2
Wells, P.S.3
-
19
-
-
85015779142
-
Validating the herdoo2 rule to guide treatment duration for women with unprovoked venous thrombosis: Multinational prospective cohort management study
-
Rodger MA, Le Gal G, Anderson DR, et al. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study. BMJ 2017;356:j1065.
-
(2017)
BMJ
, vol.356
, pp. j1065
-
-
Rodger, M.A.1
Le Gal, G.2
Anderson, D.R.3
-
20
-
-
84990179336
-
Categorization of patients as having provoked or unprovoked venous thromboembolism: Guidance from the ssc of isth
-
Kearon C, Ageno W, Cannegieter SC, et al. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost 2016;14:1480-3.
-
(2016)
J Thromb Haemost
, vol.14
, pp. 1480-1483
-
-
Kearon, C.1
Ageno, W.2
Cannegieter, S.C.3
-
21
-
-
85040810898
-
-
AnnArborMichigan USA: ProQuest LLC
-
RefWorks. AnnArbor,Michigan, USA: ProQuest LLC, 2016.
-
(2016)
RefWorks
-
-
-
22
-
-
85019181548
-
-
Covidence. Victoria Australia
-
Covidence. Covidence. Victoria, Australia, 2015.
-
(2015)
Covidence
-
-
-
23
-
-
68049122102
-
Preferred reporting items for systematic reviews and meta-Analyses: The prisma statement
-
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. PLoS med 2009;6:e1000097.
-
(2009)
PLoS Med
, vol.6
, pp. e1000097
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
-
24
-
-
84859001212
-
The cochrane collaboration's tool for assessing risk of bias in randomised trials
-
Higgins JP, Altman DG, Gøtzsche PC, et al. The cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
-
(2011)
BMJ
, vol.343
, pp. d5928
-
-
Higgins, J.P.1
Altman, D.G.2
Gøtzsche, P.C.3
-
26
-
-
80053351531
-
Conducting quantitative synthesis when comparing medical interventions: Ahrq and the effective health care program
-
Fu R, Gartlehner G, Grant M, et al. Conducting quantitative synthesis when comparing medical interventions: ahrq and the effective health care program. J clin epidemiol 2011;64:1187-97.
-
(2011)
J Clin Epidemiol
, vol.64
, pp. 1187-1197
-
-
Fu, R.1
Gartlehner, G.2
Grant, M.3
-
28
-
-
84921536011
-
Aspirin for the prevention of recurrent venous thromboembolism: The inspire collaboration
-
Simes J, Becattini C, Agnelli G, et al. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation 2014;130:1062-71.
-
(2014)
Circulation
, vol.130
, pp. 1062-1071
-
-
Simes, J.1
Becattini, C.2
Agnelli, G.3
-
31
-
-
23044505564
-
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
-
Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005;3:692-4.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 692-694
-
-
Schulman, S.1
Kearon, C.2
-
32
-
-
84920780781
-
Preferredreporting items for systematic review and meta-Analysis protocols (prisma-p 2015 statement
-
Moher D, Shamseer L, Clarke M, et al. Preferredreporting items for systematic review and meta-Analysis protocols (PRISMA-P) 2015 statement. Syst rev 2015;4:11.
-
(2015)
Syst Rev
, vol.4
, pp. 11
-
-
Moher, D.1
Shamseer, L.2
Clarke, M.3
-
33
-
-
84920843179
-
Preferred reporting items for systematic review and meta-Analysis protocols (prisma-p 2015 elaboration and explanation
-
Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-Analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;349:g7647.
-
(2015)
BMJ
, vol.349
, pp. g7647
-
-
Shamseer, L.1
Moher, D.2
Clarke, M.3
-
34
-
-
33847606952
-
Development of amstar: A measurement tool to assess the methodological quality of systematic reviews
-
Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC med res methodol 2007;7:10.
-
(2007)
BMC Med Res Methodol
, vol.7
, pp. 10
-
-
Shea, B.J.1
Grimshaw, J.M.2
Wells, G.A.3
|